New York, United States
Craniometrix, founded in 2021, offers an innovative approach to dementia care, positioning itself uniquely at the intersection of Health Care, Health and Wellness, and Senior Care. With a mission focused on empowering healthcare providers and caregivers, the company integrates the capabilities of generative AI to enhance care planning and support.
The company’s cornerstone, the GUIDE solution, equips medical practices and families with the tools needed to navigate the complexities of dementia care. By leveraging an AI-driven platform, a broad network of partner services, and the expertise of specialty-trained care navigators, Craniometrix aims to boost the quality of life for patients and those caring for them.
The U.S.-based startup raised a $6.00M Seed Round on 10 August 2022, with participation from esteemed investors like Y Combinator, Cathexis Ventures, Olive Tree Capital, Quiet Capital, Rebel Fund, J Ventures, and Defy.vc, underscoring strong market confidence in its strategic vision.
